Ultrasound Based Interventions in Gynecologic Oncology

ESGO eAcademy, Michal Zikan, 95021

Modified Gluteal Fold Advancement V-Y Flap for Vulva Reconstruction

ESGO eAcademy, Pierluigi Benedetti Panici, 94962

Pitfalls and Secondary Profit of Daphragmatic Surgery in Advanced Stages of Endometrial and Ovarian Cancer

ESGO eAcademy, Lucie Bresson, 94963

Salvage Surgery for Retroperitoneal Lymph Node Reccurence

ESGO eAcademy, David Cibula, 94964

Splenectomy with Total Omentectomy

ESGO eAcademy, David Cibula, 94965

Standardization of Type C2 Radical Hysterectomy

ESGO eAcademy, David Cibula, 94966

Perineal Pelvic Repair after Posterior Exenteration in an Epistotomy: Metastasis of Cervical Carcinoma

ESGO eAcademy, Santiago Domingo, 94967

RH in LACC Neoadjuvant RT-CHT

ESGO eAcademy, Francesco Fanfani, 94968

Ultrasound Imaging for Staging Supplemented by Corresponding Intraoperative Findings

ESGO eAcademy, Daniela Fischerova, 94969

Surgical Steps in Type B and C Laparoscopic Radical Hysterectomy: Tips and Tricks

ESGO eAcademy, Juan Gilabert-Estelles, 94970

Surgical Vascular Anatomy on the Upper Abdomen

ESGO eAcademy, Luis M. Chiva, 94971

Radical Abdominal Trachelectomy

ESGO eAcademy, Nicolae Ioanid, 94972

Sigmoid Colon Vaginoplasty

ESGO eAcademy, Ates Karakete & Ilker Kahramanoglu, 94973

Paraaortic Recurrence - Laparoscopic Resection: Retroperitoneal Approach

ESGO eAcademy, Tim Mould, 94975

Radical Resection of Intravascular and Intracardiac Tumor

ESGO eAcademy, Pedro T Ramirez, 94976

Robotic Flourescent Sentinel Node Identification in Endometrial Cancer

ESGO eAcademy, Diego Odetto, 94977

Robotic Radical Trachelectomy

ESGO eAcademy, Pedro T Ramirez, 94978

Cytoreductive Surgery & Pathophysiology of Peritoneal Carcinomatosis

ESGO eAcademy, Francesco Raspagliesi, 94979

Upper Abdominal Debulking Procedures

ESGO eAcademy, Cagatay Taskiran, 94980

Laparoscopic Access & Operating in the Retroperitoneal Space - Challenges & Pitfalls

ESGO eAcademy, Martin Widschwendter, 94981

Advanced Ovarian Cancer: Video Presenting Ultrasound Imaging for Staging Supplemented by Corresponding Intraoperative Findings

ESGO eAcademy, Daniela Fischerova, 95029

Ovarian Cancer: Cytoreductive Surgery & Pathophysiology of Peritoneal Carcinomatosis

ESGO eAcademy, Francesco Raspagliesi, 95039

CANCER DURING PREGNANCY: THE OBSTETRICAL POINT OF VIEW

ESGO eAcademy, Kristel Van Calsteren, 39121

IDENTIFICATION OF OVARIAN CANCER PATIENTS AT HIGH RISK OF SURGICAL MORBIDITY AND MORTALITY

ESGO eAcademy, Giovanni Aletti, 39122

MANAGEMENT OF GYNECOLOGIC SOFT TISSUE SARCOMA AFTER COMPLETE RESECTION

ESGO eAcademy, Isabelle Ray-Coquard, 39123

VULVAR CANCER WITH POSITIVE NODES OF THE GROIN - PELVIC LYMPHADENECTOMY, ADJUVANT RADIOTHERAPY OR RADIOCHEMOTHERAPY?

ESGO eAcademy, Sven Mahner, 39124

ISOLATED TUMOUR CELLS AND MICROMETASTASES: HOW TO DEAL WITH IT?

ESGO eAcademy, Nadeem Abu Rustum, 39125

PITFALLS IN SENTINEL NODE DETECTION IN VULVAR CANCER: AN IN DEPTH ANALYSIS OF FALSE NEGATIVE CASES

ESGO eAcademy, Maaike Oonk, 39126

QUALITY OF LIFE AND SURVIVAL AFTER SN BIOPSY. RESULTS OF THE SENTICOL II, RANDOMIZED TRIAL

ESGO eAcademy, Patrice Mathevet, 39127

ENDOMETRIAL CANCER: PREOPERATIVE ULTRASOUND ASSESSMENT TO TAILOR SURGERY

ESGO eAcademy, Elisabeth Epstein, 39118

NEW IMAGING TECHNOLOGY IN OVARIAN CANCER

ESGO eAcademy, Ate G.J. van der Zee, 39119

ULTRASOUND VERSUS MRI IN CERVICAL CANCER STAGING AND INDIVIDUAL TREATMENT PLANNING

ESGO eAcademy, Daniela Fischerova, 39120

IMAGING PRE-INVASIVE TUBAL LESIONS IN HIGH RISK POPULATIONS

ESGO eAcademy, Jessica McAlpine, 39112

TUBAL PATHOLOGY IN BRCA 1 AND 2 MUTATION CARRIERS

ESGO eAcademy, Ronny Drapkin, 39114

CONTROVERSIES IN ADJUVANT THERAPY

ESGO eAcademy, Wui-Jin Koh, 39115

CONTROVERSIES IN THE MANAGEMENT OF ADVANCED CASES IN VULVAR CANCER

ESGO eAcademy, Lukas Rob, 39116

CURRENT STATUS OF SENTINEL LYMPH NODE MAPPING IN VULVAR CANCER

ESGO eAcademy, Ate G.J. van der Zee, 39117

IMPLICATIONS FOR FUTURE RESEARCH

ESGO eAcademy, Ignace Vergote, 39341

REVIEW OF IMPLICATIONS FOR CLINICAL PRACTICE - US VIEW

ESGO eAcademy, Sean C. Dowdy, 39339

REVIEW OF IMPLICATIONS FOR CLINICAL PRACTICE - EUROPEAN VIEW

ESGO eAcademy, Nicoletta Colombo, 39338

COMPLICATIONS AND MORTALITY ASSOCIATED WITH PRIMARY OPTIMAL CYTOREDUCTION

ESGO eAcademy, Angelo Maggioni, 39109

NEOADJUVANT CHEMOTHERAPY FOR ADVANCED OVARIAN CANCER

ESGO eAcademy, Ignace Vergote, 39110

PREOPERATIVE AND LAPAROSCOPIC EVALUATION FOR OPTIMAL CYTOREDUCTION IN ADVANCED OVARIAN CANCER

ESGO eAcademy, Giovanni Scambia, 39111

GUIDELINES AND LEVEL OF EVIDENCE FROM THE TRIALS

ESGO eAcademy, John A Green, 39105

Treatment-Surgery-Lymph Nodes- Radiotherapy- Chemotherapy- Individualization- Recurrence

ESGO eAcademy, Paolo Zola, 39106

WHAT IS ENDOMETRIAL CANCER - PATHOLOGY, MOLECULAR CHARACTERISATION ETC, EPIDEMIOLOGY

ESGO eAcademy, Glenn McCluggage, 39108

IS THE THERAPY-FREE INTERVAL OF 6 MONTHS STILL A USEFUL MODEL FOR GUIDING 2NDLINE OR HIGHER THERAPIES IN OVARIAN CANCER?

ESGO eAcademy, Daniel U. Reimer, 39100

TREATMENT CONSIDERATIONS IN CERVICAL CANCER WITH PELVIC RECURRENCE AFTER ADJUVANT OR PRIMARY RADIOCHEMOTHERAPY

ESGO eAcademy, Stefano Greggi, 39101

TREATMENT CONSIDERATIONS IN PATIENTS WITH RECURRENT CARCINOMATOSIS AFTER SEVERAL LINES OF CHEMOTHERAPY AND SUBILEUS/ILEUS

ESGO eAcademy, Philipp Harter, 39102

TREATMENT CONSIDERATIONS IN VULVA CARCINOMA WITH LOCO-REGIONAL RECURRENCE

ESGO eAcademy, Ate G.J. van der Zee, 39103

PROGRESS IN RISK PREDICTION, DIAGNOSIS AND SCREENING FOR OVARIAN CANCER

ESGO eAcademy, Ian Jacobs, 39099

Vaginal Trachelectomy + Laparoscopic LND

ESGO eAcademy, Achim Schneider, 39134

Surgical Staging of Cervical Carcinoma and Extraperitoneal LND

ESGO eAcademy, Eric Leblanc, 39135

ROBOTIC SURGERY FOR THE MANAGEMENT OF CERVICAL CANCER

ESGO eAcademy, Angelo Maggioni, 39136

Vulva Cancer: VFR and Recostruction with Flaps

ESGO eAcademy, Nadja Dornhöfer, 39138

SLN in Vulvar Cancer

ESGO eAcademy, Ate G.J. van der Zee, 39139

PALLIATIVE AND END OF LIFE CARE IN GYNECOLOGICAL CANCER - GOING BEYOND THE PHYSICAL

ESGO eAcademy, Mari Lloyd-Williams, 39097

PALLIATIVE CARE - END OF LIFE CARE IN GYNECOLOGICAL CANCER : ASPECTS OF CLINICAL PRACTICE

ESGO eAcademy, Johan Menten, 39098

Cancer: A Family Affair

ESGO eAcademy, Lea Baider, 48149

Anxiety and Adjustment Disorders in Cancer Patients

ESGO eAcademy, Katalin Muszbek, 48150

Loss, Grief and Bereavement

ESGO eAcademy, David Kissane, 48151

Palliative Care for the Psycho-Oncologist

ESGO eAcademy, William Breitbart, 48152

Ethical Implications of Psycho-Oncology

ESGO eAcademy, Antonella Surbone, 48153

Psychosocial Interventions: Evidence and Methods for Supporting Cancer Patients

ESGO eAcademy, Maggie Watson & Barry Bultz, 48154

Psychosocial Assessment in Cancer Patients

ESGO eAcademy, Uwe Koch & Anja Mehnert, 48155

Communication and Interpersonal Skills in Cancer Care

ESGO eAcademy, Walter F. Baile, 48156

Distress Management in Cancer

ESGO eAcademy, Jimmie C. Holland, 48157

Depression and Depressive Disorders in Cancer Patients

ESGO eAcademy, Luigi Grassi & Yosuke Uchitomi, 48158

Guideliness and Evidence from the Trials about Follow up

ESGO eAcademy, Elisa Piovano, 45901

PERSONALIZED SURGICAL CARE FOR CERVICAL CANCER

ESGO eAcademy, Rene H.M. Verheijen, 39091

SENTINEL NODE CONCEPT AND RELEVANCE OF DETECTION OF MICROMETASTASES

ESGO eAcademy, David Cibula, 39092

(NEO-) ADJUVANT CHEMOTHERAPY AND CERVICAL CANCER

ESGO eAcademy, Roberto Angioli, 39093

NO HEALTH WITHOUT MENTAL HEALTH: THE IMPORTANCE OF PSYCHOSOCIAL CARE IN GYNAECOLOGICAL CANCER

ESGO eAcademy, Maggie Watson, 39083

PHYSICAL ACTIVITY AFTER CANCER

ESGO eAcademy, Freerk T. Baumann, 39084

POPULATION BASED OUTCOMES OF EARLY STAGE OVARIAN ENDOMETRIOID CARCINOMA (OEC) IN BRITISH COLUMBIA

ESGO eAcademy, Aalok Kumar, 39086

A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL OF WEEKLY PACLITAXEL PLUS TREBANANIB OR PLACEBO IN WOMEN WITH RECURRENT OVARIAN CANCER: TRINOVA-1

ESGO eAcademy, Bradley Monk, 39087

ICON7: FINAL OVERALL SURVIVAL RESULTS IN THE GCIG PHASE III RANDOMISED TRIAL OF BEVACIZUMAB IN NEWLY DIAGNOSED OVARIAN CANCER

ESGO eAcademy, Eric Pujade-Lauraine, 39088

RANDOMISED DOUBLE-BLIND PHASE III TRIAL OF CEDIRANIB (AZD 2171) IN RELAPSED PLATINUM SENSITIVE OVARIAN CANCER: RESULTS OF THE ICON6 TRIAL.

ESGO eAcademy, Fharat Raja, 39089

PELVIC LYMPHADENECTOMY IMPROVES SURVIVAL IN CERVICAL CANCER PATIENTS WITH LOW VOLUME DISEASE IN THE SENTINEL NODE, A RETROSPECTIVE MULTICENTRE COHORT STUDY

ESGO eAcademy, Afra Zaal, 39090

Principles of Total Omentectomy

ESGO eAcademy, Di Donato Violante, 39128

Splenectomy and Distal Pancreatectomy in Ovarian Cancer

ESGO eAcademy, Eric Leblanc, 39129

Staging Lymphadenectomy

ESGO eAcademy, Andreas Widschwendter, 39130

Modified Posterior Exenteration

ESGO eAcademy, David Cibula, 39131

Liver Mobilization and Diaphragm Peritonectomy

ESGO eAcademy, Nadeem Abu Rustum, 39132

ROBOTIC STAGING

ESGO eAcademy, K. Rainer Kimmig, 39133

HPV SELF-SAMPLING

ESGO eAcademy, Paolo Giorgi Rossi, 39077

HPV TESTING IN PRIMARY SCREENING IN LOW RESOURCES SETTINGS

ESGO eAcademy, Maribel Almonte, 39078

HPV TESTING/GENOTYPING IN PRIMARY SCREENING IN DEVELOPED COUNTRIES

ESGO eAcademy, Mario Sideri, 39079

ADAPTIVE BRACHYTHERAPY AND BEYOND IN CERVICAL CANCER TREATMENT

ESGO eAcademy, Christine Haie-Meder, 39073

LOCO REGIONAL RECURRENCES IN GYNECOLOGICAL MALIGNANCIES : TREATMENT COMPLICATIONS AND COST ANALYSIS

ESGO eAcademy, Alessandro Urgesi, 39074

HEALTH AND WELLBEING IN WOMEN

ESGO eAcademy, Peter Kinderman, 39075

PATIENT AND CLINICIAN PERSPECTIVES: A MEDICAL HUMANITIES VIEW OF THE CONSULTATION IN GYNAE ONCOLOGY.

ESGO eAcademy, Jane Macnaughton, 39076

FUNCTIONAL MR AS A BIOMARKER OF RESPONSE TO TREATMENT IN LOCALLY ADVANCED CERVICAL CANCER

ESGO eAcademy, Margaret Hall-Craggs, 45897

1ST LINE TREATMENT (SURGERY AND SYSTEMIC THERAPY) - STATE OF THE ART 2013

ESGO eAcademy, Christian Marth, 39070

PLATINUM SENSITIVE RELAPSE: THE ROLE OF SURGERY AND CURRENT STATE OF THE ART OF SYSTEMIC THERAPY

ESGO eAcademy, Philipp Harter, 39071

STATE-OF-THE ART AND NEW OPTIONS IN THE TREATMENT OF RELAPSE WITHIN A YEAR AFTER 1STLINE

ESGO eAcademy, Domenica Lorusso, 39072

PERSONALIZED THERAPY IN GYNAECOLOGIC ONCOLOGY: BIOLOGY, STRATEGY, AND ASSESSMENT

ESGO eAcademy, Anil Sood, 39064

PERSPECTIVES ON RECEPTOR TYROSINE KINASE ACTIVATION IN OVARIAN CANCER AND ITS RELATIONSHIP TO PERSONALISED MEDICINE

ESGO eAcademy, Hani Gabra, 39065

EUTHANASIA

ESGO eAcademy, Johan Menten, 39066

HIPEC ROLE IN OVARIAN CANCER

ESGO eAcademy, Anna Fagotti, 39068